Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Supreme Court Sides With Thermo Fisher In Diagnostics Patent Spat

Executive Summary

The justices struck down an appeals court ruling that a single device component could count as a “substantial portion” under patent infringement laws.

You may also be interested in...



US Urges High Court To Take Patent Case Claiming Overseas Inducement

The case between Promega and Life Tech turns on whether a company violates US patent law by shipping a single allegedly patented component overseas for assembly. The Solicitor General’s office says it does not, arguing that the Federal Circuit’s reading would expose US manufacturers to too much risk of patent liability.

Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs

A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion

OMB Clears Proposed Rule On Lab-Developed Tests

The US FDA appears poised to release long-promised regulations on lab-developed tests. However, some industry observers still have doubts as to whether the agency is truly prepared. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel